$BBIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BridgeBio Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BridgeBio Pharma, Inc.. Get notifications about new insider transactions in BridgeBio Pharma, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Director | Option Exercise | A | 62.63 | 38,895 | 2,435,994 | 38,895 | |
Jun 22 2021 | BBIO | BridgeBio Pharma, ... | DANIELS RONALD J | Director | Option Exercise | A | 62.63 | 38,895 | 2,435,994 | 38,895 | |
Jun 22 2021 | BBIO | BridgeBio Pharma, ... | SAUNDERS BRENT L | Director | Option Exercise | A | 62.63 | 38,895 | 2,435,994 | 38,895 | |
Jun 22 2021 | BBIO | BridgeBio Pharma, ... | AGUIAR ERIC | Director | Option Exercise | A | 62.63 | 38,895 | 2,435,994 | 38,895 | |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Option Exercise | M | 0.00 | 1,710 | 0 | 22,227 | |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Buy | P | 62.50 | 8,000 | 500,000 | 300,043 | 292 K to 300 K (+2.74 %) |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Payment of Exercise | F | 64.98 | 592 | 38,468 | 292,043 | 292.6 K to 292 K (-0.20 %) |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Buy | M | 0.00 | 1,710 | 0 | 292,635 | 290.9 K to 292.6 K (+0.59 %) |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Option Exercise | M | 0.00 | 5,129 | 0 | 66,682 | |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Payment of Exercise | F | 62.50 | 16,000 | 1,000,000 | 4,711,425 | 4.7 M to 4.7 M (+0.34 %) |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Payment of Exercise | F | 64.98 | 2,139 | 138,992 | 4,695,425 | 4.7 M to 4.7 M (-0.05 %) |
Feb 18 2021 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Buy | M | 0.00 | 5,129 | 0 | 4,697,564 | 4.7 M to 4.7 M (+0.11 %) |
Feb 17 2021 | BBIO | BridgeBio Pharma, ... | KKR Genetic Disorder L.P. | Sell | S | 60.47 | 3,450,000 | 208,617,360 | 31,060,971 | 34.5 M to 31.1 M (-10.00 %) | |
Feb 12 2021 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Option Exercise | A | 0.00 | 12,449 | 0 | 12,449 | |
Feb 12 2021 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Option Exercise | A | 68.87 | 73,440 | 5,057,813 | 73,440 | |
Feb 12 2021 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Option Exercise | A | 0.00 | 38,306 | 0 | 38,306 | |
Feb 12 2021 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Option Exercise | A | 68.87 | 225,971 | 15,562,623 | 225,971 | |
Jan 28 2021 | BBIO | BridgeBio Pharma, ... | Satvat Ali J. | Director | Option Exercise | A | 10.99 | 79,702 | 875,925 | 79,702 | |
Jan 28 2021 | BBIO | BridgeBio Pharma, ... | Satvat Ali J. | Director | Option Exercise | A | 16.68 | 39,851 | 664,715 | 39,851 | |
Jan 28 2021 | BBIO | BridgeBio Pharma, ... | Satvat Ali J. | Director | Option Exercise | A | 26.21 | 39,851 | 1,044,495 | 39,851 | |
Jan 26 2021 | BBIO | BridgeBio Pharma, ... | BridgeBio Pharma, Inc. | 10% Owner | Buy | P | 0.00 | 14,428,836 | 0 | 1,000 | -14,427,836 to 1,000 (-100.01 %) |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 0.16 | 6,000 | 960 | 56,042 | |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 0.34 | 6,000 | 2,040 | 31,766 | |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 17.00 | 7,500 | 127,500 | 255,500 | |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 69.94 | 8,563 | 598,855 | 12,568 | 21.1 K to 12.6 K (-40.52 %) |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 69.34 | 10,937 | 758,329 | 21,131 | 32.1 K to 21.1 K (-34.11 %) |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 0.16 | 6,000 | 960 | 32,068 | 26.1 K to 32.1 K (+23.02 %) |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 0.34 | 6,000 | 2,040 | 26,068 | 20.1 K to 26.1 K (+29.90 %) |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 17.00 | 7,500 | 127,500 | 20,068 | 12.6 K to 20.1 K (+59.68 %) |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 0.16 | 6,000 | 960 | 56,042 | |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 0.34 | 6,000 | 2,040 | 31,766 | |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 17.00 | 7,500 | 127,500 | 255,500 | |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 69.94 | 8,563 | 598,855 | 12,568 | 21.1 K to 12.6 K (-40.52 %) |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 69.34 | 10,937 | 758,329 | 21,131 | 32.1 K to 21.1 K (-34.11 %) |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 0.16 | 6,000 | 960 | 32,068 | 26.1 K to 32.1 K (+23.02 %) |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 0.34 | 6,000 | 2,040 | 26,068 | 20.1 K to 26.1 K (+29.90 %) |
Dec 29 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 17.00 | 7,500 | 127,500 | 20,068 | 12.6 K to 20.1 K (+59.68 %) |
Dec 23 2020 | BBIO | BridgeBio Pharma, ... | SCHELLER RICHARD H | See Remarks | Sell | S | 65.48 | 45,473 | 2,977,699 | 45,860 | 91.3 K to 45.9 K (-49.79 %) |
Dec 23 2020 | BBIO | BridgeBio Pharma, ... | SCHELLER RICHARD H | See Remarks | Sell | S | 64.81 | 14,928 | 967,437 | 91,333 | 106.3 K to 91.3 K (-14.05 %) |
Dec 21 2020 | BBIO | BridgeBio Pharma, ... | SCHELLER RICHARD H | See Remarks | Sell | S | 65.78 | 2,895 | 190,432 | 106,261 | 109.2 K to 106.3 K (-2.65 %) |
Dec 21 2020 | BBIO | BridgeBio Pharma, ... | SCHELLER RICHARD H | See Remarks | Sell | S | 64.99 | 27,105 | 1,761,589 | 109,156 | 136.3 K to 109.2 K (-19.89 %) |
Dec 17 2020 | BBIO | BridgeBio Pharma, ... | Sinha Uma | Chief Scientific Of ... | Option Exercise | A | 42.80 | 5,717 | 244,688 | 5,717 | |
Dec 17 2020 | BBIO | BridgeBio Pharma, ... | Sinha Uma | Chief Scientific Of ... | Option Exercise | A | 3.07 | 10,832 | 33,254 | 10,832 | |
Dec 17 2020 | BBIO | BridgeBio Pharma, ... | Sinha Uma | Chief Scientific Of ... | Option Exercise | A | 3.07 | 8,912 | 27,360 | 8,912 | |
Dec 17 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | A | 42.80 | 2,199 | 94,117 | 2,199 | |
Dec 17 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | A | 3.07 | 3,137 | 9,631 | 3,137 | |
Dec 17 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | A | 3.07 | 4,456 | 13,680 | 4,456 | |
Dec 02 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | M | 1.05 | 10,000 | 10,500 | 8,282 | |
Dec 02 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Sell | S | 51.69 | 6,972 | 360,408 | 274,211 | 281.2 K to 274.2 K (-2.48 %) |
Dec 02 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Sell | S | 51.12 | 3,028 | 154,796 | 281,183 | 284.2 K to 281.2 K (-1.07 %) |
Dec 02 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Buy | M | 1.05 | 10,000 | 10,500 | 284,211 | 274.2 K to 284.2 K (+3.65 %) |
Dec 02 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Sell | S | 30.04 | 784 | 23,549 | 261,399 | 262.2 K to 261.4 K (-0.30 %) |
Nov 25 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 17.00 | 742 | 12,614 | 263,000 | |
Nov 25 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 17.00 | 4,258 | 72,386 | 263,742 | |
Nov 25 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 47.23 | 742 | 35,044 | 12,568 | 13.3 K to 12.6 K (-5.57 %) |
Nov 25 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 17.00 | 742 | 12,614 | 13,310 | 12.6 K to 13.3 K (+5.90 %) |
Nov 25 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 47.00 | 4,258 | 200,137 | 12,568 | 16.8 K to 12.6 K (-25.31 %) |
Nov 25 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 17.00 | 4,258 | 72,386 | 16,826 | 12.6 K to 16.8 K (+33.88 %) |
Nov 18 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Option Exercise | M | 0.00 | 5,129 | 0 | 71,811 | |
Nov 18 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Payment of Exercise | F | 44.33 | 1,774 | 78,641 | 4,692,435 | 4.7 M to 4.7 M (-0.04 %) |
Nov 18 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Buy | M | 0.00 | 5,129 | 0 | 4,694,209 | 4.7 M to 4.7 M (+0.11 %) |
Nov 03 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | M | 1.05 | 10,000 | 10,500 | 28,282 | |
Nov 03 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Sell | S | 38.92 | 500 | 19,458 | 267,751 | 268.3 K to 267.8 K (-0.19 %) |
Nov 03 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Sell | S | 38.33 | 9,500 | 364,100 | 268,251 | 277.8 K to 268.3 K (-3.42 %) |
Nov 03 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Buy | M | 1.05 | 10,000 | 10,500 | 277,751 | 267.8 K to 277.8 K (+3.73 %) |
Oct 19 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Option Exercise | M | 17.00 | 10,256 | 174,352 | 260,207 | |
Oct 19 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Sell | S | 41.00 | 10,256 | 420,496 | 1,203,767 | 1.2 M to 1.2 M (-0.84 %) |
Oct 19 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Buy | M | 17.00 | 10,256 | 174,352 | 1,214,023 | 1.2 M to 1.2 M (+0.85 %) |
Oct 19 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Option Exercise | M | 17.00 | 10,256 | 174,352 | 260,207 | |
Oct 19 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Sell | S | 41.00 | 10,256 | 420,496 | 1,203,767 | 1.2 M to 1.2 M (-0.84 %) |
Oct 19 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Buy | M | 17.00 | 10,256 | 174,352 | 1,214,023 | 1.2 M to 1.2 M (+0.85 %) |
Oct 02 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 0.34 | 6,000 | 2,040 | 37,766 | |
Oct 02 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 0.16 | 6,000 | 960 | 62,042 | |
Oct 02 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 17.00 | 2,500 | 42,500 | 270,500 | |
Oct 02 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 38.24 | 2,058 | 78,707 | 12,568 | 14.6 K to 12.6 K (-14.07 %) |
Oct 02 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 37.59 | 12,442 | 467,751 | 14,626 | 27.1 K to 14.6 K (-45.97 %) |
Oct 02 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 0.34 | 6,000 | 2,040 | 27,068 | 21.1 K to 27.1 K (+28.48 %) |
Oct 02 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 0.16 | 6,000 | 960 | 21,068 | 15.1 K to 21.1 K (+39.82 %) |
Oct 02 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 17.00 | 2,500 | 42,500 | 15,068 | 12.6 K to 15.1 K (+19.89 %) |
Oct 01 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Option Exercise | M | 17.00 | 10,000 | 170,000 | 270,463 | |
Oct 01 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Sell | S | 38.00 | 10,000 | 380,000 | 1,203,767 | 1.2 M to 1.2 M (-0.82 %) |
Oct 01 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Buy | M | 17.00 | 10,000 | 170,000 | 1,213,767 | 1.2 M to 1.2 M (+0.83 %) |
Sep 29 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Sell | S | 37.50 | 18,200 | 682,500 | 1,203,767 | 1.2 M to 1.2 M (-1.49 %) |
Sep 29 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Sell | S | 37.47 | 15,396 | 576,865 | 1,221,967 | 1.2 M to 1.2 M (-1.24 %) |
Sep 29 2020 | BBIO | BridgeBio Pharma, ... | HOMCY CHARLES J | Chairman of Pharmac ... | Sell | S | 36.68 | 65,661 | 2,408,590 | 1,237,363 | 1.3 M to 1.2 M (-5.04 %) |
Sep 22 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 17.00 | 2,500 | 42,500 | 273,000 | |
Sep 22 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 42.01 | 2,500 | 105,024 | 12,568 | 15.1 K to 12.6 K (-16.59 %) |
Sep 22 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 17.00 | 2,500 | 42,500 | 15,068 | 12.6 K to 15.1 K (+19.89 %) |
Sep 22 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | M | 0.28 | 5,099 | 1,428 | 2,236 | |
Sep 22 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | M | 0.16 | 4,901 | 784 | 4,586 | |
Sep 22 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Sell | S | 40.00 | 10,000 | 400,000 | 267,751 | 277.8 K to 267.8 K (-3.60 %) |
Sep 22 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Buy | M | 0.28 | 5,099 | 1,428 | 277,751 | 272.7 K to 277.8 K (+1.87 %) |
Sep 22 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Buy | M | 0.16 | 4,901 | 784 | 272,652 | 267.8 K to 272.7 K (+1.83 %) |
Sep 18 2020 | BBIO | BridgeBio Pharma, ... | SCHELLER RICHARD H | See Remarks | Sell | S | 37.50 | 25,000 | 937,500 | 138,427 | 163.4 K to 138.4 K (-15.30 %) |
Sep 16 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 17.00 | 2,500 | 42,500 | 275,500 | |
Sep 16 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 37.06 | 2,500 | 92,652 | 12,568 | 15.1 K to 12.6 K (-16.59 %) |
Sep 16 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 17.00 | 2,500 | 42,500 | 15,068 | 12.6 K to 15.1 K (+19.89 %) |
Sep 15 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 0.34 | 2,000 | 680 | 43,766 | |
Sep 15 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 35.02 | 2,000 | 70,047 | 12,568 | 14.6 K to 12.6 K (-13.73 %) |
Sep 15 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 0.34 | 2,000 | 680 | 14,568 | 12.6 K to 14.6 K (+15.91 %) |
Sep 03 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | M | 0.16 | 10,000 | 1,600 | 9,487 | |
Sep 03 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Sell | S | 29.58 | 4,978 | 147,252 | 267,751 | 272.7 K to 267.8 K (-1.83 %) |
Sep 03 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Sell | S | 27.89 | 5,022 | 140,083 | 272,729 | 277.8 K to 272.7 K (-1.81 %) |
Sep 03 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Buy | M | 0.16 | 10,000 | 1,600 | 277,751 | 267.8 K to 277.8 K (+3.73 %) |
Sep 02 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Grant | A | 0.00 | 2,745 | 0 | 12,568 | 9.8 K to 12.6 K (+27.94 %) |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | M | 0.00 | 12,812 | 0 | 192,188 | |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Payment of Exercise | F | 28.53 | 5,460 | 155,774 | 267,751 | 273.2 K to 267.8 K (-2.00 %) |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Buy | M | 0.00 | 12,812 | 0 | 273,211 | 260.4 K to 273.2 K (+4.92 %) |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | Sinha Uma | Chief Scientific Of ... | Option Exercise | M | 0.00 | 468 | 0 | 7,032 | |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | Sinha Uma | Chief Scientific Of ... | Buy | M | 0.00 | 468 | 0 | 15,991 | 15.5 K to 16 K (+3.01 %) |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Option Exercise | M | 0.00 | 5,129 | 0 | 76,940 | |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Payment of Exercise | F | 28.53 | 1,774 | 50,612 | 4,689,080 | 4.7 M to 4.7 M (-0.04 %) |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Buy | M | 0.00 | 5,129 | 0 | 4,690,854 | 4.7 M to 4.7 M (+0.11 %) |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,595 | 0 | 23,937 | |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Payment of Exercise | F | 28.53 | 552 | 15,749 | 24,615 | 25.2 K to 24.6 K (-2.19 %) |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Buy | M | 0.00 | 1,595 | 0 | 25,167 | 23.6 K to 25.2 K (+6.77 %) |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Option Exercise | M | 0.00 | 1,709 | 0 | 25,647 | |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Payment of Exercise | F | 28.53 | 591 | 16,861 | 288,967 | 289.6 K to 289 K (-0.20 %) |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Buy | M | 0.00 | 1,709 | 0 | 289,558 | 287.8 K to 289.6 K (+0.59 %) |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | YAU YI CHING | Chief Accounting Of ... | Option Exercise | M | 0.00 | 398 | 0 | 5,985 | |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | YAU YI CHING | Chief Accounting Of ... | Payment of Exercise | F | 28.53 | 138 | 3,937 | 993 | 1.1 K to 993 (-12.20 %) |
Aug 18 2020 | BBIO | BridgeBio Pharma, ... | YAU YI CHING | Chief Accounting Of ... | Buy | M | 0.00 | 398 | 0 | 1,131 | 733 to 1.1 K (+54.30 %) |
Aug 05 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 27.54 | 403 | 11,099 | 287,116 | 287.5 K to 287.1 K (-0.14 %) |
Aug 05 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 27.20 | 2,136 | 58,097 | 287,519 | 289.7 K to 287.5 K (-0.74 %) |
Aug 05 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 28.30 | 200 | 5,659 | 289,655 | 289.9 K to 289.7 K (-0.07 %) |
Aug 05 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 27.22 | 4,461 | 121,433 | 289,855 | 294.3 K to 289.9 K (-1.52 %) |
Aug 05 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 27.36 | 6,759 | 184,914 | 2,085,372 | 2.1 M to 2.1 M (-0.32 %) |
Aug 05 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 26.70 | 7,184 | 191,846 | 2,092,131 | 2.1 M to 2.1 M (-0.34 %) |
Aug 05 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 28.12 | 3,040 | 85,498 | 2,099,315 | 2.1 M to 2.1 M (-0.14 %) |
Aug 05 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 27.23 | 63,017 | 1,715,808 | 2,102,355 | 2.2 M to 2.1 M (-2.91 %) |
Aug 05 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | M | 0.16 | 10,000 | 1,600 | 19,487 | |
Aug 05 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Sell | S | 28.11 | 1,103 | 31,006 | 260,293 | 261.4 K to 260.3 K (-0.42 %) |
Aug 05 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Sell | S | 27.28 | 8,897 | 242,735 | 261,396 | 270.3 K to 261.4 K (-3.29 %) |
Aug 05 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Buy | M | 0.16 | 10,000 | 1,600 | 270,293 | 260.3 K to 270.3 K (+3.84 %) |
Jul 06 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 30.22 | 56,445 | 1,706,022 | 2,165,372 | 2.2 M to 2.2 M (-2.54 %) |
Jul 06 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 32.42 | 2,700 | 87,521 | 2,221,817 | 2.2 M to 2.2 M (-0.12 %) |
Jul 06 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 31.67 | 33,700 | 1,067,343 | 2,224,517 | 2.3 M to 2.2 M (-1.49 %) |
Jul 06 2020 | BBIO | BridgeBio Pharma, ... | Kumar Neil | CEO and President | Sell | S | 30.63 | 50,625 | 1,550,472 | 2,258,217 | 2.3 M to 2.3 M (-2.19 %) |
Jul 06 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 32.49 | 100 | 3,249 | 294,316 | 294.4 K to 294.3 K (-0.03 %) |
Jul 06 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 31.68 | 2,800 | 88,712 | 294,416 | 297.2 K to 294.4 K (-0.94 %) |
Jul 06 2020 | BBIO | BridgeBio Pharma, ... | STEPHENSON BRIAN C | See Remarks | Sell | S | 30.64 | 7,900 | 242,092 | 297,216 | 305.1 K to 297.2 K (-2.59 %) |
Jul 06 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Option Exercise | M | 0.16 | 10,000 | 1,600 | 29,487 | |
Jul 06 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Sell | S | 32.67 | 200 | 6,533 | 260,293 | 260.5 K to 260.3 K (-0.08 %) |
Jul 06 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Sell | S | 31.77 | 2,632 | 83,629 | 260,493 | 263.1 K to 260.5 K (-1.00 %) |
Jul 06 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Sell | S | 30.63 | 7,168 | 219,539 | 263,125 | 270.3 K to 263.1 K (-2.65 %) |
Jul 06 2020 | BBIO | BridgeBio Pharma, ... | HENDERSON MICHAEL THOMAS | Chief Business Offi ... | Buy | M | 0.16 | 10,000 | 1,600 | 270,293 | 260.3 K to 270.3 K (+3.84 %) |
Jul 02 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 0.34 | 4,000 | 1,360 | 45,766 | |
Jul 02 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 0.16 | 6,000 | 960 | 68,042 | |
Jul 02 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 33.17 | 300 | 9,952 | 9,823 | 10.1 K to 9.8 K (-2.96 %) |
Jul 02 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 32.65 | 9,700 | 316,671 | 10,123 | 19.8 K to 10.1 K (-48.93 %) |